Erastin |
Inhibit system Xc−
|
HCC,27 GC,28AML,29 Calu-1,4 and HT-1080 (ref. 10) |
RSL3 |
Inhibit GPX4 directly |
HT-1080,10 143B,4 and B16 (ref. 30) |
Glutamate |
Inhibit cystine uptake |
HT-10804 and HT-22 (ref. 31) |
Sulfasalazine |
Inhibit system Xc−
|
HT-10804 and B16 (ref. 32) |
Sorafenib |
Inhibit system Xc−
|
HepG233 and HT-29 (ref. 34) |
FINO2 |
Direct oxidation of labile iron and inactivation of GPX4 |
HT-1080 (ref. 35) |
FIN56 |
Degrade GPX4 |
BC36 and HT-1080 (ref. 37) |
DPI2 |
GSH depletion |
HT-1080 and BJ cell lines19
|
Butylimine |
GSH depletion |
NA |
Cisplatin |
GSH depletion |
A54938 and A2780 (ref. 25) |
Buthionine sulfoximine |
GSH depletion |
A549,24 4T1,39 and HT-1080 (ref. 10) |